BioVie, Inc. (BIVI)
2.16
-0.03
(-1.37%)
USD |
NASDAQ |
Aug 28, 16:00
2.17
+0.01
(+0.46%)
After-Hours: 20:00
BioVie Shareholders Equity (Quarterly) : 10.27M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.27M |
| March 31, 2026 | 15.61M |
| December 31, 2025 | 19.26M |
| September 30, 2025 | 24.92M |
| June 30, 2025 | 19.01M |
| March 31, 2025 | 21.82M |
| December 31, 2024 | 23.92M |
| September 30, 2024 | 14.07M |
| June 30, 2024 | 15.51M |
| March 31, 2024 | 18.93M |
| December 31, 2023 | 7.491M |
| September 30, 2023 | 7.548M |
| June 30, 2023 | 15.34M |
| March 31, 2023 | 21.72M |
| December 31, 2022 | 26.07M |
| September 30, 2022 | 5.961M |
| June 30, 2022 | 3.671M |
| March 31, 2022 | 9.955M |
| December 31, 2021 | 16.07M |
| September 30, 2021 | 20.23M |
| June 30, 2021 | 5.050M |
| March 31, 2021 | 11.40M |
| December 31, 2020 | 13.07M |
| September 30, 2020 | 14.60M |
| June 30, 2020 | -21.50M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.344M |
| December 31, 2019 | -2.044M |
| September 30, 2019 | -8.721M |
| June 30, 2019 | 2.131M |
| March 31, 2019 | 2.785M |
| December 31, 2018 | 3.541M |
| September 30, 2018 | 4.025M |
| June 30, 2018 | 0.1112M |
| March 31, 2018 | 0.5554M |
| December 31, 2017 | 0.7911M |
| September 30, 2017 | 1.082M |
| June 30, 2017 | 1.157M |
| March 31, 2017 | 1.483M |
| December 31, 2016 | 1.327M |
| September 30, 2016 | 1.578M |
| June 30, 2016 | 1.916M |
| March 31, 2016 | -0.2115M |
| December 31, 2015 | -0.1548M |
| September 30, 2015 | -0.1068M |
| June 30, 2015 | -0.0541M |
| March 31, 2015 | -0.0012M |
| December 31, 2014 | 0.0459M |
| September 30, 2014 | 0.1145M |
| June 30, 2014 | 0.1714M |
| March 31, 2014 | 0.357M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.25M |
| Total Liabilities (Quarterly) | 3.980M |
| Debt to Equity Ratio | 0.0268 |
| Current Ratio | 3.594 |
| Net Debt Paydown Yield | 0.12% |